Akebia Therapeutics

About Akebia Therapeutics

Akebia Therapeutics is a fully integrated biopharmaceutical company focused on addressing complications of kidney disease. They aim to deliver unique products and innovate for better lives within the renal community.

Products & Services

FDA-Approved Products:Akebia has two FDA-approved products designed to address complications of kidney disease.

Specialties

Kidney Disease Treatment Research and Development in Renal Health

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Public Offering T: - FT: Public Offering	A: 50000000 MR: - FA: $50.0 million FAN: 50000000	D: 2025-03-19 FD: 2025-03-19	4 investors
2	RT: Debt T: - FT: Debt	A: 55000000 MR: - FA: 55 million FAN: 55000000	D: 2024-01-30 FD: 2024-01-30	1 investors

Public Offering Latest

2025-03-19

$50.0M

4 investors (Pro only)

Debt 2024-01-30

$55.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

John Butler

President and Chief Executive Officer

M

Meredith Bowman

Senior Vice President, Chief People Officer

S

Steven K. Burke

Senior Vice President, Research & Development and Chief Medical Officer

K

Kimberly Garko

Senior Vice President, Chief Technical Officer

N

Nicholas Grund

Senior Vice President, Chief Commercial Officer

E

Erik Ostrowski

Senior Vice President, Chief Financial Officer and Chief Business Officer

View 11 more team members with Pro

Unlock Full Team Directory

Recent News